Fidelity Investments’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.49K | Sell |
18,033
-3,955
| -18% | -$1.64K | ﹤0.01% | 4610 |
|
|
2025
Q1 | $13.7K | Sell |
21,988
-1,829,568
| -99% | -$1.14M | ﹤0.01% | 4374 |
|
|
2024
Q4 | $3.09M | Sell |
1,851,556
-4,013,550
| -68% | -$6.7M | ﹤0.01% | 2312 |
|
|
2024
Q3 | $10.7M | Sell |
5,865,106
-1,949,890
| -25% | -$3.55M | ﹤0.01% | 1898 |
|
|
2024
Q2 | $47.1M | Buy |
7,814,996
+292,184
| +4% | +$1.76M | ﹤0.01% | 1333 |
|
|
2024
Q1 | $83.9M | Buy |
7,522,812
+49,991
| +0.7% | +$557K | 0.01% | 1130 |
|
|
2023
Q4 | $111M | Buy |
7,472,821
+1,880,874
| +34% | +$28M | 0.01% | 968 |
|
|
2023
Q3 | $26.8M | Sell |
5,591,947
-538,592
| -9% | -$2.59M | ﹤0.01% | 1473 |
|
|
2023
Q2 | $46M | Buy |
6,130,539
+1,098
| +0% | +$8.25K | ﹤0.01% | 1310 |
|
|
2023
Q1 | $27.7M | Buy |
6,129,441
+16,013
| +0.3% | +$72.4K | ﹤0.01% | 1484 |
|
|
2022
Q4 | $68.9M | Buy |
6,113,428
+1,482,854
| +32% | +$16.7M | 0.01% | 1118 |
|
|
2022
Q3 | $44.3M | Buy |
4,630,574
+644,360
| +16% | +$6.17M | ﹤0.01% | 1290 |
|
|
2022
Q2 | $32.2M | Buy |
3,986,214
+427,260
| +12% | +$3.46M | ﹤0.01% | 1448 |
|
|
2022
Q1 | $60.1M | Buy |
3,558,954
+966,015
| +37% | +$16.3M | ﹤0.01% | 1318 |
|
|
2021
Q4 | $55.7M | Buy |
2,592,939
+1,333,523
| +106% | +$28.7M | ﹤0.01% | 1379 |
|
|
2021
Q3 | $93M | Sell |
1,259,416
-4,557
| -0.4% | -$337K | 0.01% | 1132 |
|
|
2021
Q2 | $69.1M | Buy |
1,263,973
+14,465
| +1% | +$791K | 0.01% | 1289 |
|
|
2021
Q1 | $92.1M | Buy |
1,249,508
+181,009
| +17% | +$13.3M | 0.01% | 1102 |
|
|
2020
Q4 | $92.1M | Buy |
1,068,499
+319,669
| +43% | +$27.6M | 0.01% | 1072 |
|
|
2020
Q3 | $28.3M | Buy |
+748,830
| New | +$28.3M | ﹤0.01% | 1427 |
|